Adaptive Biotechnologies ADPT 深 沪
交易中 09-08 11:53:10 美东时间
12.74
-0.110
-0.86%
华盛通- 最 高13.10
- 今 开12.84
- 成交量 40.39万股
- 最 低 12.64
- 昨 收 12.85
- 总市值 19.36亿
- 52周最高 13.52
- 市盈率 静 --
- 换手率 0.27%
- 52周最低 3.981
- 委 比 68.54%
- 总股本 1.52亿
- 历史最高 71.25
- 量 比 0.60
- 振 幅 3.58%
- 历史最低 2.28
- 每 手 1
- 风险率 2.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多跨国药企洞察｜罗氏加码“减肥药物”500亿美元项目部分破土动工 多项早期管线“瘦身”
（来源：动脉新医药） 编者按： 全球视野下的跨国药企深度洞察——创新、博弈与中国答卷 在全球医药产业发展的宏大叙事中，跨国药企始终扮演着关键角色——他们...
08-27 18:33
What to Expect from Sotera Health's Earnings
Sotera Health (NASDAQ:SHC) will release its quarterly earnings report on Friday...
08-07 22:04
美股大行评级 | Rivian遭多家大行下调目标价；巴克莱上调超微公司目标价从130美元升至200美元
今日重点评级关注：韦德布什：维持Gossamer Bio"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持EyePoint Pharmaceuticals"买入"评级，目标价从22美元升至23美元
08-07 09:46
Piper Sandler Maintains Overweight on Adaptive Biotechnologies, Raises Price Target to $15
Piper Sandler analyst David Westenberg maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the price target from $13 to $15.
08-06 23:54
Analysts’ Top Healthcare Picks: Cogent Biosciences (COGT), Adaptive Biotechnologies (ADPT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
08-06 18:50
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers BiomX (AMEX:PHGE) shares moved upwards by 40.1% to $0.61 during Tuesda...
08-06 05:07
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Vivakor Confirms Special Dividend of Adapti, Inc. Record Date Set for August 20, 2025
Vivakor, Inc. announced a record date of August 20, 2025, for a special dividend to shareholders. The dividend will be in the form of Adapti, Inc. common stock, with each Vivakor shareholder receiving approximately 0.0079 shares of Adapti based on the current stock price of $3.50, valuing the dividend at approximately $0.75 million. Vivakor currently holds 13.5% of Adapti's outstanding shares. Adapti recently completed its SEC registration and fi...
07-31 12:30
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.
07-26 13:25
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
Adaptive Biotechnologies announced it will report Q2 2025 financial results after market close on August 5, 2025, with a webcast conference call starting at 1:30 p.m. PT / 4:30 p.m. ET. The company specializes in translating adaptive immune system genetics into clinical products for disease diagnosis and treatment, focusing on Minimal Residual Disease and Immune Medicine. Live audio and a replay archive will be available on its website. Contact d...
07-15 20:05
